Lynn Dorsey Bleil

US·SEC (Form 4)

Amicus Therapeutics, Inc.Stericycle Inc DST Systems Inc

Cumul. flow

Total declarations

Companies

▲ Purchases (2 ops.)

€204k

▼ Sales (0 ops.)

—

Latest filing published 27 Apr 2026 for Amicus Therapeutics, INC., €1.4M. Read the official filing

Filing timeline

BuySale

Lynn Dorsey Bleil

Insider track record

Disclosed buys

Disclosed sells

T+90 hit rate

T+90 mean return

-0.9%

Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.

Signal history

Lynn Dorsey Bleil: trading record in brief

Lynn Dorsey Bleil is a declared insider at 3 companies; the most frequent names are Amicus Therapeutics, Inc., DST Systems Inc and Stericycle Inc. In total, 9 filings cover trades dated from 11 February 2016 to 27 April 2026.

Purchases make up the whole of the open-market record (2 purchases, €204k). The amount is not disclosed for 1 filing. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 5 share grants.

On 27 April 2026 came the latest disclosure, a transaction for €1.4M in Amicus Therapeutics, Inc. The most recent open-market purchase was published on 27 May 2021, 1,970 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.